Papers

1. Davis SJ and Wheldrake JF (1985) The sulphation inhibitor sodium selenate arrests the growth of Dictyostelium discoideum. FEMS Micro Lett 30, 353-358.
2. Davis SJ and Wheldrake JF (1986) Sulphation and the vegetative growth of Dictyostelium discoideum. Eur J Biochem 158, 179-185.
3. Davis SJ and Wheldrake JF (1986) Sulphation of macromolecules during thevegetative growth of Dictyostelium discoideum. In “Contemporary themes in Biochemistry” (Kon OL et al., eds) Proceedings, 4th Federation of the Asian and Oceanic Biochemists Congress. ICSU Press Cambridge pp278-279.
4. Davis SJ and Burgoyne LA (1987) The DNAse I generated disomal series iscoherent to 16N: Implications for coiling models of chromatin structure. FEBS Lett 226, 88-90.
5. Davis SJ (1988) Oligosaccharide heterogeneity of glycoproteins sulphated during the vegetative growth of Dictyostelium discoideum. J Cell Biochem 38, 77-86.
6. Davis SJ, Wheldrake JF and Freeze HH (1988) An immunological assessment of lysosomal enzymes and other macromolecules sulfated during the vegetative growth of Dictyostelium discoideum. J Cell Biochem 38, 113-116.
7. Williams AF, Davis SJ, He Q and Barclay, AN (1989) Structural diversity in domains of the immunoglobulin superfamily. Cold Spring Harbor Symposia on Quantitative Biology LIV, 637-647.
8. Davis SJ, Ward HA, Willis A, Puklavec MJ, Williams AF and Barclay AN (1990) High level expression in Chinese Hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. J Biol Chem 265, 10410-10418.
9. Davis SJ, Brady L, Barclay AN, Harlos K, Dodson, GG and Williams AF (1990) Crystallisation of a soluble form of the rat T-cell surface protein CD4 complexed with Fab from the W3/25 monoclonal antibody. J Mol Biol 213, 7-10.
10. Beyers AD, Davis SJ, Cantrell DA, Izquiendo M and Williams AF (1991) Autonomous roles for the cytoplasmic domains of the CD2 and CD4 cell surface antigens. EMBO J 10, 377-385.
11. Schockmel GA, Somoza, C, Davis SJ, Williams AF, and Healey D (1992) Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4. J Exp Med 175, 301-304.
12. Davis SJ, Schockmel GA, Somoza C, Buck DW, Healey DG, Rieber EP, Reiter C and Williams AF (1992) Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature 358, 76-79.
13. Jones EY, Davis SJ, Williams AF, Harlos K and Stuart DI (1992) Crystal structure at 2.8Å resolution of a soluble form of the cell adhesion molecule CD2. Nature 360, 232-239.
14. Davis SJ (1993) Antibody mimickry of receptors (Scientific Correspondence). Nature 361, 212.
15. Davis SJ, Puklavec MJ, Ashford DA, Harlos K, Jones EY, Stuart DI and Williams AF (1993) Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Prot Eng 6, 229-232.
16. Ashford DA, Alafi CD, Gamble VM, Mackay DJG, Rademacher TW, Williams PJ, Dwek RA, Barclay AN, Davis SJ, Somoza C, Ward HA and Williams AF (1993) Site-specific glycosylation of recombinant rat and human soluble CD4 variants expressed in Chinese Hamster ovary cells. J Biol Chem 268, 3260-3267.
17. Simon JHM, Somoza C, Schockmel GA, Collin M, Davis SJ, Williams AF and James W (1993) A rat CD4 mutant containing the gp120-binding site mediates HIV-1 infection. J Exp Med 177, 949-954.
18. Brady RL, Dodson EJ, Dodson GG, Lange G, Davis SJ, Williams AF and Barclay AN (1993) Crystal structure of domains 3 and 4 of rat CD4 and their relationship to the N-terminal domains. Science 260, 979-983.
19. van der Merwe PA, McPherson DC, Brown MH, Barclay AN, Cyster JG, Williams AF and Davis SJ (1993) The NH2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2. Eur J Immunol 23, 1373-1377.
20. van der Merwe PA, Brown MH, Davis SJ and Barclay AN (1993) Measuring very low affinity interactions between immunoglobulin superfamily cell-adhesion molecules. Biochem Soc Trans 21, 340S.
21. Davis SJ, James WS, Schockmel GA, Simon JHM, Somoza C (1993) The recognition of chimeras of rat and human CD4 by HIV-1 gp120 and by monoclonal antibodies. Philos Trans R Soc Lond B Biol Sci 342, 75-81.
22. Barclay AN, Brady RL, Davis SJ and Lange G (1993) CD4 and the Immunoglobulin Superfamily. Philos Trans R Soc Lond B Biol Sci 342, 7-12.
23. Dwek RA, Ashford DA, Edge CJ, Parekh RB, Rademacher TW, Barclay AN, Davis SJ and Williams AF (1993) Glycosylation of CD4 and Thy-1. Philos Trans R Soc Lond B Biol Sci 342, 43-50.
24. Davis SJ, Jones EY, Bodian DL, Barclay AN and van der Merwe PA (1993) Analysis of the structure and interactions of CD2. Biochem Soc Trans 21, 952-958.
25. van der Merwe PA, Brown MH, Davis SJ and Barclay AN (1993) Affinity and kinetic analysis of the interaction of soluble, monomeric forms of rat CD2 and CD48. EMBO J, 12, 4945-54.
26. Tavernor AS, Kydd JH, Bodian DL, Jones EY, Stuart DI, Davis SJ and Butcher GW (1993) Expression cloning of an equine T-lymphocyte glycoprotein CD2 cDNA: structure-based analysis of conserved sequence elements. Eur J Biochem 219, 969-76.
27. Kieffer B, Driscoll PC, Campbell ID, Willis AC, van der Merwe PA and Davis SJ (1994) Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 33, 4471-82.
28. Bodian DL, Jones EY, Harlos K, Stuart DI and Davis SJ (1994) Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5Å resolution. Structure 2, 755-66.
29. van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, Tone M, Krishnam AK, Ianelli C and Davis SJ (1994) Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33, 10149-60.
30. Silkowski H, Byron O, Davis SJ, Barclay AN, Davies EA, Rowe AJ and Harding SE (1995) Estimation of the dissociation constant of the cell adhesion molecules srCD2 and srCD48 using analytical ultracentrifugation. Biochem Soc Trans 23, 435S.
31. Davis SJ, Davies EA and van der Merwe PA (1995) Mutational analysis of the epitopes recognized by anti-(rat CD2) and anti-(rat CD48) monoclonal antibodies. Biochem Soc Trans 23, 188-94.
32. Fischer PB, Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA and Platt FM (1995) The alpha-glucosidase inhibitor N-butyldeoxy-nojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J Virol 69, 5791-5797.
33. Davis SJ, Davies EA, Barclay AN, Daenke S, Bodian DL, Jones EY, Stuart DI, Butters TD, Dwek RA and van der Merwe PA (1995) Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent. J Biol Chem 270, 369-75.
34. van der Merwe PA, McNamee PN, Davies EA, Barclay AN and Davis SJ (1995) Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr Biol 5, 74-84.
35. McAllister MSB, Mott MR, van der Merwe PA, Campbel ID, Davis SJ and Driscoll PC (1996) NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48. Biochemistry 35, 5982-5991.
36. Davis SJ and van der Merwe PA (1996) The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today 17, 177-187.
37. Davis SJ and van der Merwe PA (1996) CD2: an exception to the Immunoglobulin Superfamily concept? Science 273, 1241.
38. Bodian DL, Davis SJ, Morgan BP and Rushmere NK (1997) Mutational analysis of the active site of the complement-inhibitory glycoprotein, CD59. J Exp Med 185, 507-16.
39. Rudd PM, Morgan BP, Wormald MR, Harver DJ, van der Berg CW, Davis SJ, Ferguson MAJ and Dwek RA (1997) The glycosylation of the complement regulatory protein, human erythrocyte CD59. J Biol Chem 272, 7229-7244.
40. van der Merwe PA, Bodian DL, Daenke S, Linsley PS and Davis SJ (1997) B7-1 (CD80) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 185, 393-403.
41. Silkowski H, Byron O, Davis SJ, Barclay AN, Rowe AJ and Harding SE (1997) Characterisation of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation. Eur J Biophys 25, 455-462.
42. Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA (1997) Roles for glycosylation in the anti-inflammatory molecule CD59. Biochem Soc Trans 25, 1177-1184.
43. Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA (1998) The glycosylation of the complement regulatory protein, human erythrocyte CD59. Adv Exp Med Biol 435, 153-162.
44. Davis SJ, Davies EA, Tucknott MG, Jones EY, van der Merwe PA (1998) The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. Proc Natl Acad Sci USA 95, 5490-5494.
45. Davis SJ, Ikemizu S, Wild MK, van der Merwe PA (1998) CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol Rev 163, 217-36.
46. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, Bell JI, van der Merwe PA, Jakobsen BK (1999) T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity 10, 219-225.
47. Ikemizu S, Sparks LM, van der Merwe PA, Harlos K, Stuart DI, Jones EY, Davis SJ (1999) Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-Å resolution. Proc Natl Acad Sci USA 96, 4289-4294.
48. Rudd PM, Wormald MR, Harvey DJ, Devasahayam M, McAlister MS, Brown MH, Davis SJ, Barclay AN, Dwek RA (1999) Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells. Glycobiology 9, 443-458.
49. Butters TD, Sparks LM, Harlos K, Ikemizu S, Stuart DI, Jones EY, Davis SJ (1999) Additive effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells application to glycoprotein crystallisation. Proteins 8, 1696-1701.
50. Ikemizu S; Gilbert RJC; Fennelly JA; Collins AV; Harlos K; Jones EY; Stuart DI, Davis SJ (2000) Structure and dimerisation of a soluble form of B7-1(CD80). Immunity 12, 51-60.
51. Brodie D, Collins AV, Iaboni A, Fennelly JA, Sparks LM, Xu X,k van der Merwe PA; Davis SJ (2000) LICOS, a primordial costimulatory ligand? Curr Biol 10, 333-336.
52. Pellicci DG, Kortt AA, Sparrow LG, Hudson PJ, Sorensen HV, Davis SJ, Classon BJ. (2000) Expression and purification of antigenically active soluble derivatives of the heterodimeric and homodimeric forms of the mouse CD8 lymphocyte membrane glycoprotein. J Immunol Methods 246, 149-63.
53. 53. van der Merwe PA, Davis SJ, Shaw AS, Dustin ML. (2000) Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin Immunol 2000 12, 5-21.
54. 54. Mavaddat N, Mason DW, Atkinson PD, Evans EJ, Gilbert RJ, Stuart DI, Fennelly JA, Barclay AN, Davis SJ, Brown MH. (2000) Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J Biol Chem 2000 275, 28100-28109.
55. Vorup-Jensen T, Petersen SV, Hansen AG, Poulsen K, Schwaeble W, Sim RB, Reid KB, Davis SJ, Thiel S, Jensenius JC. (2000) Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 165, 2093-100.
56. Davis SJ, Ikemizu S, Collins AV, Fennelly JA, Harlos K, Jones EY, Stuart DI. (2001) Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1. Acta Crystallogr D Biol Crystallogr 57, 605-608.
57. Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, Stahl ML, Seehra J, Somers WS, Mosyak L. (2001) Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608-611.
58. Davis SJ, van der Merwe PA (2001) Immunological synapse: required for T cell receptor signaling or directing T cell effector function? Curr Biol 11, R89.
59. Ikemizu S, Jones EY, Stuart DI and Davis SJ (2001) Structure studies on the leukocyte co-stimulatory molecule, B7-1. In “Activating and Inhibitory Immunoglobulin-Like Receptors” (Eds, M.D. Cooper, T. Takai and J.V. Ravetch) Springer-Verlag Tokyo, pp 63-72.
60. Fennelly JA, Tiwari B, Davis SJ, Evans EJ (2001). CD2F-10: a new member of the CD2 subset of the immunoglobulin superfamily. Immunogenetics 2001 53, 599-602.
61. Bromley SK, Iaboni A, Davis SJ, Whitty A, Green, JM Shaw AS, Weiss A, Dustin ML (2001) The immunological synapse and CD28-CD80 interactions. Nature Immunology 2, 1159-1166.
62. van der Merwe PA and Davis SJ (2002) The immunological synapse - a multi-tasking system. Science 295, 1479-1480.
63. Wheeler SF, Rudd PM, Davis SJ, Dwek RA, Harvey DJ (2002) Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells. Glycobiology 12, 261-271.
64. Collins AV, Brodie DW, Gilbert RJC, Iaboni A, Stuart DI, van der Merwe PA, Davis SJ (2002) Interaction properties of costimulatory molecules revisited. Immunity 17, 201-210.
65. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR van der Merwe PA (2003) The nature of molecular recognition by T cells. Nature Immunol 4, 217-224.
66. van der Merwe PA and Davis SJ (2003) Molecular interactions mediating T cell antigen recognition. Ann Rev Immunol 21, 659-684.
67. Merry AH, Gilbert RJ, Shore DA, Royle L, Miroshnychenko O, Vuong M, Wormald MR, Harvey DJ, Dwek RA, Classon BJ, Rudd PM, Davis SJ (2003) O-glycosylation and the structure of the stalk-like region of the T cell coreceptor CD8 J Biol Chem 278, 27119-27128.
68. Luhder F, Huang Y, Muller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hunig, T (2003) Topological requirements of T-cell activating anti-CD28 antibody superagonists. J Exp Med 21, 955-966.
69. Evans EJ, Hene L, Sparks LM, Dong T, Retiere C, Fennelly JA, Manso-Sancho R, Powell J, Braud VM, Rowland-Jones SL, McMichael AJ, Davis SJ (2003) The T cell surface – how well do we know it? Immunity 19, 213-223.
70. Love CA, Harlos K, Mavaddat N, Davis SJ, Stuart DI, Jones EY, Esnouf RM (2003) The ligand-binding face of the semaphorins revealed by the high resolution structure of SEMA4D. Nat Struct Biol 10, 843-848.
71. Brown J, Walter TS, Carter NGA et al. (2003) A procedure for setting up high-throughput nanolitre crystallization experiments. II Crystallization results. J Appl Cryst 36, 315-318.
72. Davis SJ, van der Merwe PA (2003) TCR triggering: co-receptor-dependent or -independent? Trends Immunol 24, 624-626.
73. Abidi SHI, Dong T, McMichael AJ, Rowland-Jones SL, Davis SJ (2004) Transcriptional remodelling by CD8 antibodies in HIV-specific CD8 T cells secreting anti-viral factors that inhibit HIV and SIV replication. Proceedings of the XV International AIDS Conference, 131-135.
74. Jansson A, Barnes E, Klenerman P, Harlen M, Sorensen P, Davis SJ, Nilsson P (2005) A theoretical framework for quantitative analysis of the molecular basis of costimulation. J Immunol 175, 1575-1585.
75. Evans EJ, Esnouf RM, Manso-Sancho R, Gilbert RJ, James JR, Yu C, Fennelly JA, Vowles C, Hanke T, Walse B, Hunig T, Sorensen P, Stuart DI, Davis SJ (2005) Crystal structure of a soluble CD28-Fab complex. Nat Immunol 6, 271-279.
76. James ES, Harney S, Wordsworth BP, Cookson WO, Davis SJ, Moffatt MF (2005) PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun 6, 430-437.
77. Crispin M, Harvey DJ, Chang VT, Yu C, Aricescu AR, Jones EY, Davis SJ, Dwek RA, Rudd PM (2006) Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology 16, 748-756.
78. Evans EJ, Castro MA, O'brien R, Kearney A, Walsh H, Sparks LM, Tucknott MG, Davies EA, Carmo AM, van der Merwe PA, Stuart DI, Jones EY, Ladbury JE, Ikemizu S, Davis SJ (2006) Crystal structure and binding properties of the CD2 and CD244 (2B4) binding protein CD48. J Biol Chem 281, 29309-29320
79. Davis SJ, van der Merwe PA (2006) The kinetic-segregation model: TCR triggering and beyond. Nat Immunol 7, 803-809
80. Aricescu AR, Assenberg R, Bill RM, Busso D, Chang VT, Davis SJ, Dubrovsky A, Gustafsson L, Hedfalk K, Heinemann U, Jones IM, Ksiazek D, Lang C, Maskos K, Messerschmidt A, Macieira S, Peleg Y, Perrakis A, Poterszman A, Schneider G, Sixma TK, Sussman JL, Sutton G, Tarboureich N, Zeev-Ben-Mordehai T, Jones EY (2006) Eukaryotic expression: developments for structural proteomics. Acta Crystallogr D Biol Crystallogr 62, 1114-1124
81. James JR, Oliveira MI, Carmo AM, Iaboni A, Davis SJ (2006) A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 3, 1001-1006
82. James JR, Davis SJ(2007) Reply to: BRET analysis of GPCR oligomerization: newer does not mean better. Nat Methods 4, 4
83. Nettleship JE, Aplin R, Radu Aricescu A, Evans EJ, Davis SJ, Crispin M, Owens RJ (2007) Analysis of variable N-glycosylation site occupancy in glycoproteins by liquid chromatography electrospray ionization mass spectrometry. Anal Biochem 361, 149-151
84. Kearney A, Avramovic A, Castro MA, Carmo AM, Davis SJ, van der Merwe PA (2007) The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction. J Biol Chem 282, 13160-13166
85. Chang VT, Crispin M, Aricescu AR, Harvey DJ, Nettleship JE, Fennelly JA, Yu C, Boles KS, Evans EJ, Stuart DI, Dwek RA, Jones EY, Owens RJ, Davis SJ (2007) Glycoprotein structural genomics: solving the glycosylation problem. Structure 15, 267-273
86. Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, Cecchinato V, Vaccari M, Tryniszewska E, Gostick E, Roederer M, Douek DC, Morgan SH, Davis SJ, Franchini G, Koup RA. (2007) SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110, 928-936
87. Berlanga O, Bori-Sanz T, James JR, Frampton J, Davis SJ, Tomlinson MG, Watson SP (2007) Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost 5, 1026-1033
88. Crispin M, Aricescu AR, Chang VT, Jones EY, Stuart DI, Dwek RA, Davis SJ, Harvey DJ (2007) Disruption of alpha-mannosidase processing induces non-canonical hybrid-type glycosylation. FEBS Lett 581, 1963-1968
89. Chirifu M, Hayashi C, Nakamura T, Toma S, Shuto T, Kai H, Yamagata Y, Davis SJ, Ikemizu S (2007) Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans. Nat Immunol 8, 1001-1007
90. James JR, Davis SJ (2007) Reply to: Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat Methods 4, 601
91. Aricescu AR, Siebold C, Choudhuri K, Chang VT, Lu W, Davis SJ, van der Merwe PA, Jones EY (2007) Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science 317, 1217-1220
92. Hene L, Sreenu VB, Vuong MT, Abidi SH, Sutton JK, Rowland-Jones SL, Davis SJ, Evans EJ (2007) Deep analysis of cellular transcriptomes - LongSAGE versus classic MPSS. BMC Genomics 8, 333
93. James JR, White SS, Clarke RW, Johansen AM, Dunne PD, Sleep DL, Fitzgerald WJ, Davis SJ, Klenerman D (2007) Single-molecule level analysis of the subunit composition of the T cell receptor on live T cells. Proc Natl Acad Sci USA 104, 17662-17667
94. Schimanski LM, Drakesmith H, Talbott C, Horne K, James JR, Davis SJ, Sweetland E, Bastin J, Cowley D, Townsend AR (2007) Ferroportin: Lack of evidence for multimers. Blood Cells Mol Dis [Epub ahead of print]

Books

1. Barclay AN, Beyers AD, Birkeland ML, Brown MH, Davis SJ, Somoza C and Williams AF (1993) The Leukocyte Antigen FactsBook. Academic Press. London.

home | research | papers | simon davis | ed evans | co-workers | contacts | search